UK Heatwave Drives Surge in Fan and Ice Cube Sales Retailers Report Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office Certificate of Deposit Rates Continue to Offer Attractive Yields for Savers in 2026 SpaceXs Potential 175 Trillion IPO Historical Patterns Suggest Possible 32 Decline Within a Year NOXCAT Emphasizes Staking for LongTerm Ecosystem Growth Over ShortTerm Yield Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Operational Momentum EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization TUSK Q1 2026 Earnings Profitability Achieved with EPS of 010 Stock Declines Slightly Bunge BG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency LOPE Q1 2026 Earnings EPS Surpasses Estimates Stock Slips Slightly CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Orion SA OEC Q1 2026 Earnings A Miss on EPS Weighs on Performance but Shares Rally Title Cantor Equity Partners II Inc CEPT Slips 122 Consolidation Near Support as Traders Eye Key Levels SailPoint Inc SAIL Shows Resilience Trading Near Resistance After 393 Gain Hurco HURC Holds Near Key Support in a Tight Trading Range Highview Merger Corp HVMC Holds Steady at 1012 as Investors Await Catalysts Lyft Inc LYFT Shows Modest Gains as Shares Hover Near Support Scotiabank Flags Lower Rent Growth Expectations for MidAmerica Apartment Communities MAA SPCB Q4 2025 Earnings Stunning EPS Beat Surprises Market Tailwind 20 Acquisition Corp TDWD SPAC Holds Steady at 100 Consolidation or Calm Before the Catalyst Medline Inc MDLN Q1 2026 Earnings EPS Surpasses Estimates by 949 Amidst Limited Revenue Disclosure Titan America Q1 2026 Earnings EPS Misses Consensus Yet Shares Rally Mativ Holdings MATV Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Reaction TaoWeave Inc TWAV Q3 2022 Earnings Significant EPS Miss Sends Stock Lower Live Ventures Q1 2026 Earnings Positive EPS Reported Amid Limited Disclosure WILC Q4 2025 Earnings Solid EPS Despite Absence of Revenue Guidance Stock Dips 336 DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist